Filing Summary: Fresenius Medical Care AG & Co. KGaA
Business Context and Reporting Period
This Form 6-K was filed on October 17, 2018, by Fresenius Medical Care AG & Co. KGaA, a German partnership limited by shares. The filing covers the month of October 2018 and serves to furnish press releases and ad-hoc announcements to the U.S. Securities and Exchange Commission.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document acts as a cover sheet for exhibits rather than a financial statement.
Material Changes
No material financial changes or comparative period data are detailed within the text of this Form 6-K. The filing references the issuance of a press release and an ad-hoc announcement on October 16, 2018, but does not summarize their content.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, or specific risk factors. It solely indicates the submission of Exhibit 99.1 (Press Release) and Exhibit 99.2 (Ad-hoc announcement) which likely contain such information.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release issued October 16, 2018) for the specific news event triggering this filing.
- Review Exhibit 99.2 (Ad-hoc announcement) for regulatory disclosures required under Art. 17 (1) MAR.
- Verify the identity of the signatories: Rice Powell (CEO) and Michael Brosnan (CFO).
- Confirm that the registrant files annual reports under Form 20-F.